cystic fibrosis, Alzheimer’s, Duchnene muscular dystrophy (DMD), and other chronic musculoskeletal disorders. The FDA recently approved CRISPR to treat sickle cell disease, an inherited disorder ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

The programme utilises Intellia's clustered regularly interspaced short palindromic repeats (CRISPR)-based gene ... "ReCode to secure funds for cystic fibrosis gene correction treatments" was ...

CRISPR Therapeutics already has financial backing from Celgene and in October announced a discovery alliance with Vertex in cystic fibrosis. Novartis has a stake in rivals Intellia Therapeutics ...

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

Cystic fibrosis (CF) is a life-threatening genetic ... The team developed their CF rabbit model using CRISPR/Cas9 gene-editing technology. Rabbits with CF exhibited hallmark pancreatic changes ...

CRISPR & Cas Genes Market Growing funding in gene therapy worldwide is a prominent factor driving the CRISPR & Cas genes market.